Search
Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.
Cancer treatments like chemotherapy may cause cognitive changes, which experts call “chemo brain.” Learn how Memorial Sloan Kettering experts help patients with this condition.
A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
Learn how MSK research on a family of rare blood cancers called histiocytosis is leading to new targeted therapies that benefit patients.
Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.
Medical physicist Lawrence Dauer explains what you should know about the use and safety of tests such as CT scans that use radiation to obtain images of the body.
El físico médico Lawrence Dauer explica lo que debe saber sobre el uso y la seguridad de pruebas como las tomografías computarizadas, que utilizan radiación para obtener imágenes del cuerpo.
Learn how a new MSK treatment approach preserves patients' noses while effectively treating nasal cavity cancer.
During the opening clinical plenary of the American Association for Cancer Research (AACR) virtual annual meeting I on Monday, April 27, Memorial Sloan Kettering’s Charles Sawyers, MD served as a discussant and featured thought leader on two phase III BRAF-mutant melanoma trials, providing commentary and a broader outlook on the highlighted clinical trials.
Anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) have modified the protective boxes commonly employed during airway procedures in infectious patients, such as intubation, creating a two-piece setup instead of the usual single unit.